| Company Name | Pfizer |
|---|---|
| Protocol Number | B3461001 |
| Title of Study | TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS OUTCOMES SURVEY (THAOS): A GLOBAL, MULTI-CENTER, LONGITUDINAL, OBSERVATIONAL SURVEY OF PATIENTS WITH DOCUMENTED TRANSTHYRETIN (TTR) MUTATIONS OR WILD-TYPE TTR AMYLOIDOSIS |
| Primary Objective | To better understand the natural history of transthyretin amyloidoses (hereditary and wild-type forms) and the progression of disease in this patient population |
| Number of Sites | 1 |
| Period of Study | From：2019/03 to：2021/12/24 |
| Number of Patients | NA人 |
| IRB Approval Date | 2017/06/29 |
| Publication Plan / Date | NA |
